Cargando…
Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid
Docosahexaenoic acid (C22:6n-3, DHA) is the precursor of specialized pro-resolving lipid mediators (SPMs), such as resolvin, protectin, and maresin families which have been considered therapeutic bioactive compounds for human health. Growing evidence indicates that DHA and SPMs are beneficial strate...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421104/ https://www.ncbi.nlm.nih.gov/pubmed/37571256 http://dx.doi.org/10.3390/nu15153317 |
_version_ | 1785088884526284800 |
---|---|
author | Beyer, María Paz Videla, Luis A. Farías, Camila Valenzuela, Rodrigo |
author_facet | Beyer, María Paz Videla, Luis A. Farías, Camila Valenzuela, Rodrigo |
author_sort | Beyer, María Paz |
collection | PubMed |
description | Docosahexaenoic acid (C22:6n-3, DHA) is the precursor of specialized pro-resolving lipid mediators (SPMs), such as resolvin, protectin, and maresin families which have been considered therapeutic bioactive compounds for human health. Growing evidence indicates that DHA and SPMs are beneficial strategies in the amelioration, regulation, and duration of inflammatory processes through different biological actions. The present review discusses the reported therapeutic benefits of SPMs on various diseases and their potential clinical applications. |
format | Online Article Text |
id | pubmed-10421104 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104211042023-08-12 Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid Beyer, María Paz Videla, Luis A. Farías, Camila Valenzuela, Rodrigo Nutrients Review Docosahexaenoic acid (C22:6n-3, DHA) is the precursor of specialized pro-resolving lipid mediators (SPMs), such as resolvin, protectin, and maresin families which have been considered therapeutic bioactive compounds for human health. Growing evidence indicates that DHA and SPMs are beneficial strategies in the amelioration, regulation, and duration of inflammatory processes through different biological actions. The present review discusses the reported therapeutic benefits of SPMs on various diseases and their potential clinical applications. MDPI 2023-07-26 /pmc/articles/PMC10421104/ /pubmed/37571256 http://dx.doi.org/10.3390/nu15153317 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Beyer, María Paz Videla, Luis A. Farías, Camila Valenzuela, Rodrigo Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid |
title | Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid |
title_full | Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid |
title_fullStr | Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid |
title_full_unstemmed | Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid |
title_short | Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid |
title_sort | potential clinical applications of pro-resolving lipids mediators from docosahexaenoic acid |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421104/ https://www.ncbi.nlm.nih.gov/pubmed/37571256 http://dx.doi.org/10.3390/nu15153317 |
work_keys_str_mv | AT beyermariapaz potentialclinicalapplicationsofproresolvinglipidsmediatorsfromdocosahexaenoicacid AT videlaluisa potentialclinicalapplicationsofproresolvinglipidsmediatorsfromdocosahexaenoicacid AT fariascamila potentialclinicalapplicationsofproresolvinglipidsmediatorsfromdocosahexaenoicacid AT valenzuelarodrigo potentialclinicalapplicationsofproresolvinglipidsmediatorsfromdocosahexaenoicacid |